A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.
- 1 August 1992
- journal article
- review article
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 11 (4) , 445-456
- https://doi.org/10.1080/07315724.1992.10718249
Abstract
In 1919, glucose intolerance became the earliest recognized metabolic abnormality in cancer patients. Prior to the development of severe malnutrition, colon, gastric, sarcoma, endometrial, prostate, localized head, neck, and lung cancer patients had many of the metabolic abnormalities of type II (noninsulin dependent) diabetes mellitus. These metabolic abnormalities include glucose intolerance, an increase in both hepatic glucose production (HGP) and glucose recycling, and insulin resistance. In a study of over 600 cancer patients, a diabetic pattern of glucose tolerance test was noted in over one-third of the patients. An increased rate of HGP, commonly seen in diabetics, has been noted in almost all types of cancer patients studied to date. Etiology of the increased glucose production in the cancer patient is not known, but abnormalities in the counter regulatory hormones, especially growth hormone, may contribute to the development of abnormal glucose metabolism. A second possible stimulus for the increase in HGP could be the glucose needs of the tumor. Abnormally high glucose utilization rates in small amounts of tumor tissue have recently been described. This suggests that small tumors may have large needs for glucose calories. An increase in anaerobic glycolysis in the tumor tissue can increase lactate production in the tumor-bearing human, thus supplying substrate to the liver to increase glucose production rates. In this paper, the nature of abnormal glucose metabolism in cancer patients is described.Keywords
This publication has 71 references indexed in Scilit:
- Gut exchange of glucose and lactate in basal state and after oral glucose ingestion in postoperative patientsDiabetes, 1990
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- Increased Urinary Excretion of Cortisol and Catecholami-NES in Malnourished Cancer PatientsAnnals of Surgery, 1988
- Insulin resistance in patients with colorectal cancerBritish Journal of Surgery, 1987
- The Oxidation of Body Fuel Stores in Cancer PatientsAnnals of Surgery, 1986
- Thermic Effect and Substrate Oxidation in Response to Intravenous Nutrition in Cancer Patients who Lose WeightAnnals of Surgery, 1986
- Glucose intolerance in sarcoma patientsCancer, 1984
- Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patientsCancer, 1982
- A controlled, prospective, randomized trial evaluating the metabolic effects of enteral and parenteral nutrition in the cancer patientCancer, 1982
- Total Parenteral Nutrition in the Cancer PatientNew England Journal of Medicine, 1981